Everest Medicines Ltd. held its Annual General Meeting on June 27, 2025. The proposals included the adoption of the audited consolidated financial statements for the year ended December 31, 2024, along with the reports from the directors and independent auditor. All proposed resolutions were approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.